This page contains brief information about mobocertinib succinate and a collection of links to more information about the use of this drug, research results, and ongoing clinical trials.
Use in Cancer
Mobocertinib succinate is approved to treat:
- Non-small cell lung cancer (NSCLC) that is locally advanced or metastatic and got worse during or after platinum chemotherapy. It is used in adults whose cancer has certain EGFR gene mutations.
Mobocertinib succinate is also being studied in the treatment of other conditions.
More About Mobocertinib Succinate
Definition from the NCI Drug Dictionary - Detailed scientific definition and other names for this drug.
Research Results and Related Resources
Clinical Trials Accepting Patients
Find Clinical Trials for Mobocertinib Succinate - Check for trials from NCI's list of cancer clinical trials now accepting patients.